Literature DB >> 12410701

Reliance on erythema scores may mask severe atopic dermatitis in black children compared with their white counterparts.

M A Ben-Gashir1, R J Hay.   

Abstract

BACKGROUND: The prevalence of atopic dermatitis (AD) has been shown to be higher in London-born black Caribbean children than in their white counterparts, but little is known about the severity of the disease.
OBJECTIVES: To carry out a longitudinal survey to investigate potential risk factors for AD severity in children. We report our findings in relation to differences in disease severity between white and black children and the effect of inclusion and exclusion of erythema scores on this comparison.
METHODS: The recruited children were identified by their general practitioners (GPs) as having presented with AD, and the U.K. diagnostic criteria for AD were used to verify the diagnosis. Interview and clinical examination of children took place up to four times, 6 months apart. Each time, the same observer assessed AD severity using the SCORAD (SCORe Atopic Dermatitis) index. Potential risk factors and confounders were evaluated with a five-page questionnaire. Non-parametric tests were used for statistical analysis and the study participant remained the unit of the analysis.
RESULTS: In total, 137 children (82 urban and 55 rural) were recruited, and each seen up to four times. This gave 380 observations (69% of an expected 548). The urban population contained 42 (51%) white children, 26 (32%) black children and 14 (17%) from other races. The rural population was entirely white. The 14 children from other races were completely excluded from the statistical analysis. The black children were all born in the U.K. On crude analysis, children with black skin showed a non-significantly lower risk of severe disease when compared with white children (odds ratio, OR 0.84; 95% confidence interval, CI 0.4-1.76; P = 0.65), while a highly significantly increased risk was found after adjusting for erythema score (OR 5.93; 95% CI 1.94-18.12; P = 0.002). The difference remained significant even after controlling for other potential confounders.
CONCLUSIONS: Black children with AD are about six times more at risk of having severe AD than their white counterparts. GPs and dermatologists should note that erythema can be a misleading indicator of severity in black children. Difficulties of assessment due to skin pigmentation might mean that severe cases are not being detected and appropriately treated.

Entities:  

Mesh:

Year:  2002        PMID: 12410701     DOI: 10.1046/j.1365-2133.2002.04965.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  14 in total

1.  Dermatological evaluation in patients with skin of colour: the effect of erythema on outcome measures in atopic dermatitis.

Authors:  P B Chansky; L Mittal; V P Werth
Journal:  Br J Dermatol       Date:  2017-04       Impact factor: 9.302

2.  Quantitation of epidermal and mucosal tissue injury using contrast agents and imaging techniques.

Authors:  Marty O Visscher; David Sullivan; Steven Sullivan; Brian Barford; Murray Dock; Marilyn S Sommers
Journal:  Skin Res Technol       Date:  2009-05       Impact factor: 2.365

3.  The reliability and validity of outcome measures for atopic dermatitis in patients with pigmented skin: A grey area.

Authors:  C Y Zhao; A Wijayanti; M C Doria; A G Harris; S V Jain; K N Legaspi; N C Dlova; M G Law; D F Murrell
Journal:  Int J Womens Dermatol       Date:  2015-08-06

4.  Extent and consequences of inadequate disease control among adults with a history of moderate to severe atopic dermatitis.

Authors:  Wenhui Wei; Peter Anderson; Abhijit Gadkari; Stuart Blackburn; Rachel Moon; James Piercy; Shashank Shinde; Jorge Gomez; Eric Ghorayeb
Journal:  J Dermatol       Date:  2017-11-13       Impact factor: 4.005

Review 5.  Resolving the etiology of atopic disorders by using genetic analysis of racial ancestry.

Authors:  Jayanta Gupta; Elisabet Johansson; Jonathan A Bernstein; Ranajit Chakraborty; Gurjit K Khurana Hershey; Marc E Rothenberg; Tesfaye B Mersha
Journal:  J Allergy Clin Immunol       Date:  2016-06-11       Impact factor: 10.793

6.  Hyperspectral imaging and characterization of allergic contact dermatitis in the short-wave infrared.

Authors:  Tommy Du; Deependra K Mishra; Leonid Shmuylovich; Andy Yu; Helena Hurbon; Steven T Wang; Mikhail Y Berezin
Journal:  J Biophotonics       Date:  2020-06-18       Impact factor: 3.207

7.  Assessment of acquired hemophilia patient demographics in the United States: the Hemostasis and Thrombosis Research Society Registry.

Authors:  Craig M Kessler; Alice D Ma; Hamid A B Al-Mondhiry; Robert Z Gut; David L Cooper
Journal:  Blood Coagul Fibrinolysis       Date:  2016-10       Impact factor: 1.276

Review 8.  The role of bacterial skin infections in atopic dermatitis: expert statement and review from the International Eczema Council Skin Infection Group.

Authors:  H Alexander; A S Paller; C Traidl-Hoffmann; L A Beck; A De Benedetto; S Dhar; G Girolomoni; A D Irvine; P Spuls; J Su; J P Thyssen; C Vestergaard; T Werfel; A Wollenberg; M Deleuran; C Flohr
Journal:  Br J Dermatol       Date:  2019-12-04       Impact factor: 9.302

9.  Differences in Psychometric Properties of Clinician- and Patient-Reported Outcome Measures for Atopic Dermatitis by Race and Skin Tone: A Systematic Review.

Authors:  Trisha Kaundinya; Uros Rakita; Armaan Guraya; Donna Maria Abboud; Emily Croce; Jacob P Thyssen; Andrew Alexis; Jonathan I Silverberg
Journal:  J Invest Dermatol       Date:  2021-08-02       Impact factor: 8.551

10.  Transcriptomic analysis of atopic dermatitis in African Americans is characterized by Th2/Th17-centered cutaneous immune activation.

Authors:  Shannon Wongvibulsin; Nishadh Sutaria; Suraj Kannan; Martin Prince Alphonse; Micah Belzberg; Kyle A Williams; Isabelle D Brown; Justin Choi; Youkyung Sophie Roh; Thomas Pritchard; Raveena Khanna; Amarachi C Eseonu; Jaroslaw Jedrych; Carly Dillen; Madan M Kwatra; Anna L Chien; Nathan Archer; Luis A Garza; Xinzhong Dong; Sewon Kang; Shawn G Kwatra
Journal:  Sci Rep       Date:  2021-05-27       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.